For citations:
Peda E.S., Alexandrov T.L., Baranova T.A., Belous S.S., Tishaeva I.A., Nanaeva B.A., Shapina M.V., Knyazev O.V., Eligulashvili R.R., Belinskaya V.A., Podolskaya D.V. The effectiveness and safety of switching therapy with an original drug to biosimilars in treatment of inflammatory bowel diseases. Experimental and Clinical Gastroenterology. 2021;(11):35-41. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-195-11-35-41
Email this article 